189 related articles for article (PubMed ID: 25760809)
21. Epstein-Barr virus (EBV) latent membrane protein-1 down-regulates tumor necrosis factor-alpha (TNF-alpha) receptor-1 and confers resistance to TNF-alpha-induced apoptosis in T cells: implication for the progression to T-cell lymphoma in EBV-associated hemophagocytic syndrome.
Chuang HC; Lay JD; Chuang SE; Hsieh WC; Chang Y; Su IJ
Am J Pathol; 2007 May; 170(5):1607-17. PubMed ID: 17456766
[TBL] [Abstract][Full Text] [Related]
22. Induction of IκB-ζ by Epstein-Barr virus latent membrane protein-1 and CD30.
Ishikawa C; Senba M; Mori N
Int J Oncol; 2015 Dec; 47(6):2197-207. PubMed ID: 26498461
[TBL] [Abstract][Full Text] [Related]
23. RUNX3 is oncogenic in natural killer/T-cell lymphoma and is transcriptionally regulated by MYC.
Selvarajan V; Osato M; Nah GSS; Yan J; Chung TH; Voon DC; Ito Y; Ham MF; Salto-Tellez M; Shimizu N; Choo SN; Fan S; Chng WJ; Ng SB
Leukemia; 2017 Oct; 31(10):2219-2227. PubMed ID: 28119527
[TBL] [Abstract][Full Text] [Related]
24. Dual expression of Epstein-Barr virus, latent membrane protein-1 and human papillomavirus-16 E6 transform primary mouse embryonic fibroblasts through NF-κB signaling.
Shimabuku T; Tamanaha A; Kitamura B; Tanabe Y; Tawata N; Ikehara F; Arakaki K; Kinjo T
Int J Clin Exp Pathol; 2014; 7(5):1920-34. PubMed ID: 24966902
[TBL] [Abstract][Full Text] [Related]
25. Roles of BIM induction and survivin downregulation in lapatinib-induced apoptosis in breast cancer cells with HER2 amplification.
Tanizaki J; Okamoto I; Fumita S; Okamoto W; Nishio K; Nakagawa K
Oncogene; 2011 Sep; 30(39):4097-106. PubMed ID: 21499301
[TBL] [Abstract][Full Text] [Related]
26. The PTEN-AKT-mTOR/RICTOR Pathway in Nasal Natural Killer Cell Lymphoma Is Activated by miR-494-3p via PTEN But Inhibited by miR-142-3p via RICTOR.
Chen HH; Huang WT; Yang LW; Lin CW
Am J Pathol; 2015 May; 185(5):1487-99. PubMed ID: 25907832
[TBL] [Abstract][Full Text] [Related]
27. Metastatic function of BMP-2 in gastric cancer cells: the role of PI3K/AKT, MAPK, the NF-κB pathway, and MMP-9 expression.
Kang MH; Oh SC; Lee HJ; Kang HN; Kim JL; Kim JS; Yoo YA
Exp Cell Res; 2011 Jul; 317(12):1746-62. PubMed ID: 21570392
[TBL] [Abstract][Full Text] [Related]
28. Acacetin (5,7-dihydroxy-4'-methoxyflavone) exhibits in vitro and in vivo anticancer activity through the suppression of NF-κB/Akt signaling in prostate cancer cells.
Kim HR; Park CG; Jung JY
Int J Mol Med; 2014 Feb; 33(2):317-24. PubMed ID: 24285354
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disorder in children and young adults has similar molecular signature to extranodal nasal natural killer/T-cell lymphoma but shows distinctive stem cell-like phenotype.
Ng SB; Ohshima K; Selvarajan V; Huang G; Choo SN; Miyoshi H; Shimizu N; Reghunathan R; Chua HC; Yeoh AE; Quah TC; Koh LP; Tan PL; Chng WJ
Leuk Lymphoma; 2015; 56(8):2408-15. PubMed ID: 25382618
[TBL] [Abstract][Full Text] [Related]
30. LIM and SH3 protein 1 induces glioma growth and invasion through PI3K/AKT signaling and epithelial-mesenchymal transition.
Zhong C; Li X; Tao B; Peng L; Peng T; Yang X; Xia X; Chen L
Biomed Pharmacother; 2019 Aug; 116():109013. PubMed ID: 31146105
[TBL] [Abstract][Full Text] [Related]
31. Akt is upstream and MAPKs are downstream of NF-κB in paclitaxel-induced survival signaling events, which are down-regulated by curcumin contributing to their synergism.
Bava SV; Sreekanth CN; Thulasidasan AK; Anto NP; Cheriyan VT; Puliyappadamba VT; Menon SG; Ravichandran SD; Anto RJ
Int J Biochem Cell Biol; 2011 Mar; 43(3):331-41. PubMed ID: 20883815
[TBL] [Abstract][Full Text] [Related]
32. [Bortezomib Inhibits Extranodal Natural Killer/T Cell Lymphoma, Nasal Type by Targeting NF-κB Signaling Pathway].
Li JH; Zhang L; Feng Y; Zou LQ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 May; 50(3):311-316. PubMed ID: 31631595
[TBL] [Abstract][Full Text] [Related]
33. [Expression and its significance of STAT3, STAT5, Survivin and Ki67 in nasal NK/T cell lymphoma].
Yue L; Cheng J; Zhang Pf; Lin G; Yi Z; Zhang R
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Oct; 20(20):931-3, 936. PubMed ID: 17225522
[TBL] [Abstract][Full Text] [Related]
34. EBV LMP-1 negatively regulates expression and pro-apoptotic activity of Par-4 in nasopharyngeal carcinoma cells.
Lee JW; Liu PF; Hsu LP; Chen PR; Chang CH; Shih WL
Cancer Lett; 2009 Jul; 279(2):193-201. PubMed ID: 19250735
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of survivin via activation of ERK1/2, Akt, and NF-κB plays a central role in vincristine resistance in multiple myeloma cells.
Tsubaki M; Takeda T; Ogawa N; Sakamoto K; Shimaoka H; Fujita A; Itoh T; Imano M; Ishizaka T; Satou T; Nishida S
Leuk Res; 2015 Apr; 39(4):445-52. PubMed ID: 25726084
[TBL] [Abstract][Full Text] [Related]
36. Cytotoxic granular protein expression, Epstein-Barr virus strain type, and latent membrane protein-1 oncogene deletions in nasal T-lymphocyte/natural killer cell lymphomas from Mexico.
Elenitoba-Johnson KS; Zarate-Osorno A; Meneses A; Krenacs L; Kingma DW; Raffeld M; Jaffe ES
Mod Pathol; 1998 Aug; 11(8):754-61. PubMed ID: 9720504
[TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr virus latent membrane protein 1 induces CD69 expression through activation of nuclear factor-κB.
Ishikawa C; Mori N
Int J Oncol; 2013 May; 42(5):1786-92. PubMed ID: 23546309
[TBL] [Abstract][Full Text] [Related]
38. Gallic acid inhibits gastric cancer cells metastasis and invasive growth via increased expression of RhoB, downregulation of AKT/small GTPase signals and inhibition of NF-κB activity.
Ho HH; Chang CS; Ho WC; Liao SY; Lin WL; Wang CJ
Toxicol Appl Pharmacol; 2013 Jan; 266(1):76-85. PubMed ID: 23153558
[TBL] [Abstract][Full Text] [Related]
39. Survival advantage of EBV-associated gastric carcinoma: survivin up-regulation by viral latent membrane protein 2A.
Hino R; Uozaki H; Inoue Y; Shintani Y; Ushiku T; Sakatani T; Takada K; Fukayama M
Cancer Res; 2008 Mar; 68(5):1427-35. PubMed ID: 18316606
[TBL] [Abstract][Full Text] [Related]
40. Transactivation of CCL20 gene by Epstein-Barr virus latent membrane protein 1.
Okudaira T; Yamamoto K; Kawakami H; Uchihara JN; Tomita M; Masuda M; Matsuda T; Sairenji T; Iha H; Jeang KT; Matsuyama T; Takasu N; Mori N
Br J Haematol; 2006 Feb; 132(3):293-302. PubMed ID: 16409294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
